Skip to main content

Table 4 Changes in CDRS-R Item scores from baseline to week 8 (mixed-model repeated measures)

From: Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination

CDRS-R item (Item #)

OFC, N = 170 mean baseline (SD)

OFC, N = 170 LS mean change (SE)

Placebo, N = 84 mean baseline (SD)

Placebo, N = 84 LS mean change (SE)

Between-group p value

Total

54.6 (10.0)

−28.4 (1.1)

53.7 (8.2)

−23.4 (1.5)

0.003

Impaired schoolwork (1)

4.1 (1.4)

−1.92 (0.1)

4.0 (1.3)

−1.5 (0.2)

0.019

Difficulty having fun (2)

4.5 (1.2)

−2.7 (0.1)

4.7 (1.1)

−2.2 (0.2)

0.023

Social withdrawal (3)

3.9 (1.2)

−2.3 (0.1)

4.0 (1.2)

−1.8 (0.2)

0.003

Sleep disturbance (4)

3.4 (1.3)

−2.1 (0.1)

3.4 (1.3)

−1.3 (0.1)

<.001

Appetite disturbance (5)

2.4 (1.2)

−0.5 (0.1)

2.7 (1.3)

−0.8 (0.2)

0.171

Excessive fatigue (6)

4.0 (1.5)

−2.3 (0.1)

3.9 (1.7)

−2.2 (0.2)

0.488

Physical complaints (7)

2.8 (1.5)

−1.4 (0.1)

2.8 (1.4)

−1.2 (0.1)

0.170

Irritability (8)

4.3 (1.5)

−2.3 (0.1)

4.1 (1.5)

−1.7 (0.2)

0.004

Excessive guilt (9)

2.7 (1.5)

1.5 (0.1)

2.5 (1.5)

−1.2 (0.1)

0.053

Low self-esteem (10)

3.8 (1.4)

−2.1 (0.1)

3.6 (1.3)

−1.7 (0.2)

0.019

Depressed feelings (11)

4.6 (1.1)

−2.9 (0.1)

4.5 (1.1)

−2.4 (0.2)

0.005

Morbid ideation (12)

2.2 (1.3)

−0.8 (0.1)

2.0 (1.3)

−0.8 (0.1)

0.780

Suicidal ideation (13)

1.3 (0.7)

−0.2 (0.1)

1.2 (0.6)

−0.16 (0.1)

0.430

Excessive weeping (14)

2.8 (1.6)

−1.5 (0.1)

2.5 (1.6)

−1.5 (0.1)

0.897

Depressed facial affect (15)

3.4 (1.2)

−1.9 (0.1)

3.2 (1.2)

−1.6 (0.1)

0.067

Listless speech (16)

2.1 (0.8)

−0.9 (0.1)

2.2 (0.9)

−1.0 (0.1)

0.857

Hypoactivity (17)

2.4 (1.1)

−1.2 (0.1)

2.4 (1.1)

−1.0 (0.1)

0.166

  1. CDRS-R children’s depression rating scale-revised, LS least squares, N number of patients, OFC olanzapine/fluoxetine combination, SD standard deviation, SE standard error